DPIIT recognised startup Government of India
Startup India
Medyrex E-Pharm Private Limited
Medyrex E-Pharm Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.16 Lakh
▲ 52% YoY
Net loss · FY 2025
₹4.66 Lakh
Net margin -35.4%
EBITDA · FY 2025
-₹4.66 Lakh
EBITDA margin -35.4%
Authorised capital
₹21 Lakh
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Brands
1
Associated brands
About Medyrex E-Pharm Private Limited
Data last updated:
Medyrex E-Pharm Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 03 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2021PTC157597.
The company has an authorised share capital of ₹21 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Shanti Tunk and Supraja Pandi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 8 – 2 – 703 Road No. 12 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.16 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net loss of ₹4.66 Lakh (net margin -35.4%) and EBITDA of -₹4.66 Lakh (EBITDA margin -35.4%).
The company is associated with 1 brand: HOMED India.
Company details
CIN U85100TG2021PTC157597
Registration Number 157597
Incorporation Date 03 December 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Shanti Tunk Director Supraja Pandi Director Recognitions & Rankings of Medyrex E-Pharm
Contact details
Medyrex E-Pharm Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH. No. 8 – 2 – 703 Road No. 12 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryHealthcare, Preventive Health Supplements
To see the full contact details of Medyrex E-Pharm Private Limited, buy the company report.
Comprehensive company report
Medyrex E-Pharm Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medyrex E-Pharm operates one associated brand: HOMED India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers an online platform for home delivery of purchased medicines. | homedindia.com |
Business activity
The main business activity of Medyrex E-Pharm is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Medyrex E-Pharm Private Limited, buy the company report.
Financials of Medyrex E-Pharm Private Limited
FY 2025 filings availableMedyrex E-Pharm Private Limited reported revenue of ₹13.16 Lakh (up 52% YoY) for FY 2025.
Revenue · FY 2025
₹13.16 Lakh ▲ 52%
Net loss · FY 2025
₹4.66 Lakh margin -35.4%
EBITDA · FY 2025
-₹4.66 Lakh margin -35.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 52%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▼ 23%
Revenue rose 52% in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹4.66 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹4.66 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -35.4% | |||
| Net Profit Margin | -35.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medyrex E-Pharm Private Limited, buy the company report.
Board of directors of Medyrex E-Pharm Private Limited
Medyrex E-Pharm has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shanti Tunk | Director | 12 Jul 2023 | 3 Years 3 Months | Current |
| Supraja Pandi | Director | 16 May 2025 | 1 Years 5 Months | Current |
Auditor
Medyrex E-Pharm Private Limited is audited by VISHNU REDDY & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VISHNU REDDY & ASSOCIATES | FY 2022 | 018533S |
Shareholding
The shareholding of Medyrex E-Pharm Private Limited is on record for FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medyrex E-Pharm Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medyrex E-Pharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medyrex E-Pharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medyrex E-Pharm Private Limited has 1 active EPFO establishment as of Apr 01, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Medyrex E-Pharm Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medyrex E-Pharm Private Limited has 10 board changes on record since 2021: 4 appointments and 6 cessations. The latest: Sowmya Nandhi ceased to be Additional Director on 29 Sep 2025.
AGM
Medyrex E-Pharm Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Sowmya Nandhi ceased to be Additional Director.
Ceased
Supraja Pandi ceased to be Additional Director.
Appointed
Supraja Pandi was appointed as Director.
Filing
Medyrex E-Pharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Sowmya Nandhi was appointed as Director.
Ceased
Vinod ceased to be Director.
Ceased
Durgasi Reddy ceased to be Director.
Ceased
Shanti Tunk ceased to be Additional Director.
Appointed
Shanti Tunk was appointed as Director.
Ceased
Sheetal Rajoriya ceased to be Director.
Appointed
Vinod was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Medyrex E-Pharm is an active private limited company based in Hyderabad, Telangana, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 03 December 2021 (5+ years old) and is registered under CIN U85100TG2021PTC157597.
Medyrex E-Pharm has 2 current directors:
- Shanti Tunk - Director
- Supraja Pandi - Director
The latest financial statements of Medyrex E-Pharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Medyrex E-Pharm is U85100TG2021PTC157597. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medyrex E-Pharm was incorporated on 03 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sowmya Nandhi ceased to be Additional Director on 29 Sep 2025. Supraja Pandi ceased to be Additional Director on 29 Sep 2025. Supraja Pandi was appointed as Director on 16 May 2025. Medyrex E-Pharm has 10 board changes on record in total.
Yes, Medyrex E-Pharm is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Medyrex E-Pharm is at H. No. 8 – 2 – 703 Road No. 12 Banjara Hills, Hyderabad, Telangana, India – 500034.
Medyrex E-Pharm operates in the healthcare industry, in the preventive health supplements segment.
Medyrex E-Pharm has 1 associated brand: Homed India.